Antonella D'Arminio Monforte
Antonella D'Arminio Monforte
Affiliazione sconosciuta
Email verificata su unimi.it
Titolo
Citata da
Citata da
Anno
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
19562003
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
M Egger, M May, G Chŕne, AN Phillips, B Ledergerber, F Dabis, ...
The Lancet 360 (9327), 119-129, 2002
19062002
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
Antiretroviral Therapy Cohort Collaboration
The Lancet 372 (9635), 293-299, 2008
16342008
Changing patterns of mortality across Europe in patients infected with HIV-1
A Mocroft, S Vella, TL Benfield, A Chiesi, V Miller, P Gargalianos, ...
The Lancet 352 (9142), 1725-1730, 1998
15431998
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft, B Ledergerber, C Katlama, O Kirk, P Reiss, AA Monforte, ...
The Lancet 362 (9377), 22-29, 2003
15012003
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-M°ller, ...
Archives of internal medicine 166 (15), 1632-1641, 2006
13262006
Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study
N Friis-M°ller, R Weber, P Reiss, R ThiÚbaut, O Kirk, AA Monforte, ...
Aids 17 (8), 1179-1193, 2003
12352003
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration
CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ...
The Lancet 384 (9939), 241-248, 2014
6932014
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverseá…
SW Worm, C Sabin, R Weber, P Reiss, W El-Sadr, F Dabis, S De Wit, ...
The Journal of infectious diseases 201 (3), 318-330, 2010
6932010
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
AA Monforte, AC Lepri, G Rezza, P Pezzotti, A Antinori, AN Phillips, ...
Aids 14 (5), 499-507, 2000
6732000
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature
A Ammassari, MP Trotta, R Murri, F Castelli, P Narciso, P Noto, J Vecchiet, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S123-S127, 2002
6162002
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.
A Ammassari, R Murri, P Pezzotti, MP Trotta, L Ravasio, P De Longis, ...
Journal of acquired immune deficiency syndromes (1999) 28 (5), 445-449, 2001
6072001
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D: A: D) study
S De Wit, CA Sabin, R Weber, SW Worm, P Reiss, C Cazanave, ...
Diabetes care 31 (6), 1224-1229, 2008
4982008
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
A Trickey, MT May, JJ Vehreschild, N Obel, MJ Gill, HM Crane, ...
The lancet HIV 4 (8), e349-e356, 2017
4552017
Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing
E Girardi, CA Sabin, AA Monforte
JAIDS Journal of Acquired Immune Deficiency Syndromes 46, S3-S8, 2007
4072007
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study
A Mocroft, R Brettle, O Kirk, A Blaxhult, JM Parkin, F Antunes, P Francioli, ...
Aids 16 (12), 1663-1671, 2002
3792002
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
E Fontas, F Van Leth, CA Sabin, N Friis-M°ller, M Rickenbach, ...
The Journal of infectious diseases 189 (6), 1056-1074, 2004
3782004
Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons
A Ammassari, A Antinori, MS Aloisi, MP Trotta, R Murri, L Bartoli, ...
Psychosomatics 45 (5), 394-402, 2004
3472004
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-M°ller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
3412010
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy
G Marchetti, GM Bellistrý, E Borghi, C Tincati, S Ferramosca, ...
Aids 22 (15), 2035-2038, 2008
3152008
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20